InfographIcs

Explore our infographics to learn more about dolutegravir and Dovato (dolutegravir/lamivudine).

Dovato

SALSA 48 week study one-pager

View the infographic sharing the top-line results from the SALSA study at 48 weeks

View infographic

Dovato

STAT (test-and-treat) 48-week study one-pager

View the infographic sharing the top-line results from the STAT study on test and treat out to 48 weeks

View infographic

Dovato

TANGO 144-week study one-pager

View the infographic sharing the top-line results from the TANGO study out to 144 weeks

View infographic

Dovato

GEMINI 144 Study Infographic

View the latest Dovato infographics and discover more on the patient with this one-pager GEMINI 144 resource for HCPs

View infographic

Dovato

Patient booklet for post-prescription Dovato (dolutegravir/lamivudine)

A downloadable patient leaflet for prescribers to download and share with their patients. This should not be directly downloaded by patients as this site is intended for HCPs only.

Other resources

Resources

Watch experts in HIV share the details of Dovato studies and watch internal and external experts share their opinions on the latest data.

Resources

Catch up on conference symposia, webinars and meeting presentations and learn more about the latest data for Dovato.

PM-GB-HVX-WCNT-200021 v2 | June 2021